Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|November 28, 2008
Long-term follow-up of a population based cohort with monoclonal proteinaemiaCees G Schaar, Saskia le Cessie, Simone Snijder, et al.
British Journal of Haematology|December 2, 2016
Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine)Michael Lübbert, Gabriele Ihorst, Philipp N Sander, et al.
British Journal of Haematology|January 25, 2003
A novel 7.9 kb deletion causing alpha+-thalassaemia in two independent families of Indian originCornelis L Harteveld, Peter van Delft, Pierre W Wijermans, et al.
Haematologica|September 2, 2018
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcomeJulia Stomper, Gabriele Ihorst, Stefan Suciu, et al.
Transfusion|June 20, 2008
The clinical impact of platelet refractoriness: correlation with bleeding and survivalJean-Louis H Kerkhoffs, Jeroen C J Eikenboom, Leo M G van de Watering, et al.
Hemoglobin|February 2, 2010
Hb Den Haag [beta45(CD4)Phe-->Tyr]. A new hemoglobin variant observed during early pregnancy diagnosticsJudith O Kaufmann, Cornelis L Harteveld, Margreet Bakker-Verweij, et al.
Annals of Hematology|June 7, 2020
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemiaHeiko Becker, Dietmar Pfeifer, Gabriele Ihorst, et al.
Haematologica|October 13, 2005
Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphomaMichel van Agthoven, Mark H H Kramer, Pieter Sonneveld, et al.
Blood|November 1, 2007
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trialEdo Vellenga, Wim L J van Putten, Mars B van 't Veer, et al.
Haematologica|July 4, 2007
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trialPieter Sonneveld, Bronno van der Holt, Christine M Segeren, et al.
Pageof 5